Use of Sodium Valproate and Other Anti-Seizure Medications in England and Wales During the COVID-19 Pandemic: A Population-Level Analysis of 60 Million Individuals (2023)

First Author: Dale C

Attributed to: Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.4544777

Publication URI: http://dx.doi.org/10.2139/ssrn.4544777

Type: Preprint